Search
for
Sort by
Research 211–240 of 788
- 218 Chemokine receptor CCR5 is the novel target for the treatment of alopecia areata
- Alopecia Areata
- Pharmacological Treatment of Alopecia
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- Alopecia Areata: Current Review
- Kaempferol enhances hair growth by regulating JAK3/STAT6 and TGF-β/Smad signaling in human dermal papilla cells and a C57BL/6 mousemodel
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- 0527 Effectiveness of janus kinase inhibitor for rapidly progressive acute alopecia areata
- Hemp Seed-Derived Exosomes Protect Against Dihydrotestosterone-Induced Chicken Feather Growth Inhibition
- Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: A retrospective cohort study
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Under Development JAK Inhibitors for Dermatologic Diseases
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Alopecia Areata: Case report and review of pathophysiology and treatment with Jak inhibitors
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- JAK Inhibitors for Treatment of Alopecia Areata
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles